Neuropathic joint disease: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 20: Line 20:


If this pathological process continues unchecked, it could result in joint deformity, [[ulcer]]ation and/or [[superinfection]], loss of function, and in the worst case scenario: [[amputation]].  Early identification of joint changes is the best way to limit morbidity.
If this pathological process continues unchecked, it could result in joint deformity, [[ulcer]]ation and/or [[superinfection]], loss of function, and in the worst case scenario: [[amputation]].  Early identification of joint changes is the best way to limit morbidity.
==Pathophysiology==
*Two primary theories have been advanced:
**''Neurotrauma'':  Loss of peripheral sensation and proprioception leads to repetitive [[microtrauma]] to the joint in question; this damage goes unnoticed by the neuropathic patient, and the resultant inflammatory resorption of traumatized bone renders that region weak and susceptible to further trauma.  Indeed, it is a [[vicious cycle]]. In addition, poor fine motor control generates unnatural pressure on certain joints, leading to additional microtrauma.
**''Neurovascular'':  Neuropathic patients have dysregulated [[autonomic nervous system]] reflexes, and de-sensitized joints receive significantly greater blood flow.  The resulting [[hyperemia]] leads to increased osteoclastic resorption of bone, and this, in concert with mechanical stress, leads to bony destruction.


==Pathogenesis==
In reality, both of these theories probably play a role in the development of a Charcot joint.
==Causes==
Basically, any condition resulting in decreased peripheral sensation, [[proprioception]], and fine [[motor control]]:
Basically, any condition resulting in decreased peripheral sensation, [[proprioception]], and fine [[motor control]]:
*[[Diabetes mellitus]] [[neuropathy]] (the most common in the U.S. today, resulting in destruction of foot and ankle joints), with Charcot joints in 1/600-700 diabetics.  Related to long-term poor glucose control.  
*[[Diabetes mellitus]] [[neuropathy]] (the most common in the U.S. today, resulting in destruction of foot and ankle joints), with Charcot joints in 1/600-700 diabetics.  Related to long-term poor glucose control.  
Line 33: Line 38:
*[[Syringomyelia]]
*[[Syringomyelia]]
*Intra-articular [[steroid]] injections
*Intra-articular [[steroid]] injections
 
==Differentiating Neuropathic joint disease from other Diseases==
===Underlying Mechanisms===
Note that it is often difficult to differentiate [[osteomyelitis]] from a Charcot joint, as they may have similar tagged WBC scan and [[MRI]] features (joint destruction, dislocation, edema).   Definitive diagnosis may require bone or synovial biopsy.
*Two primary theories have been advanced:
==Diagnosis==
**''Neurotrauma'':  Loss of peripheral sensation and proprioception leads to repetitive [[microtrauma]] to the joint in question; this damage goes unnoticed by the neuropathic patient, and the resultant inflammatory resorption of traumatized bone renders that region weak and susceptible to further trauma.  Indeed, it is a [[vicious cycle]]. In addition, poor fine motor control generates unnatural pressure on certain joints, leading to additional microtrauma.
===History and Symptoms===
**''Neurovascular'':  Neuropathic patients have dysregulated [[autonomic nervous system]] reflexes, and de-sensitized joints receive significantly greater blood flow.  The resulting [[hyperemia]] leads to increased osteoclastic resorption of bone, and this, in concert with mechanical stress, leads to bony destruction.
 
In reality, both of these theories probably play a role in the development of a Charcot joint.
 
===Joint Involvement===
As diabetes is the #1 cause in America today for neuropathic joint disease, the foot is the most affected region.  In those with foot deformity, approximately 60% are in the [[TMT]] joint (medial > lateral), 30% MCP joint, and 10% have ankle disease.  Over half of diabetic patients with neuropathic joints can recall some kind of precipitating trauma, usually minor.
As diabetes is the #1 cause in America today for neuropathic joint disease, the foot is the most affected region.  In those with foot deformity, approximately 60% are in the [[TMT]] joint (medial > lateral), 30% MCP joint, and 10% have ankle disease.  Over half of diabetic patients with neuropathic joints can recall some kind of precipitating trauma, usually minor.


Line 48: Line 48:
Hip joint destruction is also seen in neuropathic patients.
Hip joint destruction is also seen in neuropathic patients.


==Clinical Findings==
===Physical Examination===
[[Erythema]], [[edema]], increased temperature in the affected joint.  In neuropathic foot joints, plantar ulcers may be present.  Note that it is often difficult to differentiate [[osteomyelitis]] from a Charcot joint, as they may have similar tagged WBC scan and [[MRI]] features (joint destruction, dislocation, edema).  Definitive diagnosis may require bone or synovial biopsy.
[[Erythema]], [[edema]], increased temperature in the affected joint.  In neuropathic foot joints, plantar ulcers may be present.  
 
===X Ray===
==Radiologic Findings==
First, it is important to recognize that two types of abnormality may be detected.  One is termed "[[atrophic]]," in which there is [[osteolysis]] of the distal [[metatarsal]]s in the [[forefoot]].  The more common form of destruction is "[[hypertrophic]]" joint disease, characterized by acute peri-articular [[fracture]] and [[joint]] [[dislocation]].
First, it is important to recognize that two types of abnormality may be detected.  One is termed "atrophic," in which there is [[osteolysis]] of the distal metatarsals in the forefoot.  The more common form of destruction is "hypertrophic" joint disease, characterized by acute peri-articular fracture and joint dislocation.


The natural history of the joint destruction process has a classification scheme of its own, offered by Eichenholtz decades ago:
The natural history of the joint destruction process has a classification scheme of its own, offered by Eichenholtz decades ago:


'''Stage 0:'''  Clinically, there is joint edema, but radiographs are negative.  Note that a bone scan may be positive before a radiograph is, making it a sensitive but not very specific modality.
'''Stage 0:'''  Clinically, there is joint [[edema]], but radiographs are negative.  Note that a bone scan may be positive before a radiograph is, making it a sensitive but not very specific modality.


'''Stage 1:'''  Osseous fragmentation with joint dislocation seen on radiograph ("acute Charcot").
'''Stage 1:'''  [[Osseous]] fragmentation with joint dislocation seen on radiograph ("acute Charcot").


'''Stage 2:'''  Decreased local edema, with coalescence of fragments and absorption of fine bone debris
'''Stage 2:'''  Decreased local edema, with coalescence of fragments and absorption of fine bone debris


'''Stage 3:'''  No local edema, with consolidation and remodeling (albeit deformed) of fracture fragments.  The foot is now stable.
'''Stage 3:'''  No local edema, with consolidation and [[remodeling]] (albeit deformed) of fracture fragments.  The foot is now stable.


Destroyed TMT joints in the medial left foot,  with fracture and dislocation of fragments; these are classic findings.  Also note loss of the foot arch and acquired pes planus deformity.
Destroyed TMT joints in the medial left foot,  with fracture and dislocation of fragments; these are classic findings.  Also note loss of the foot arch and acquired pes planus deformity.
==Treatment==
==Treatment==
 
Once the process is recognized, immobilization with a total contact [[cast]] will help ward off further joint destruction. [[Pneumatic]] [[walking braces]] are also used.  Surgical correction of a joint is rarely successful in the long-term in these patients.
Once the process is recognized, immobilization with a total contact [[cast]] will help ward off further joint destruction. [[Pneumatic]] [[walking braces]] are also used.  Surgical correction of a joint is rarely successful in the long-term in these patients.


It can take 6-9 months for the edema and erythema of the affected joint to recede.
It can take 6-9 months for the edema and erythema of the affected joint to recede.
Line 77: Line 74:
*Gupta, R.  1993.  A short history of neuropathic arthropathy.  [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8222448&dopt=Abstract Clinical Orthopaedics], 296, pp. 43-49.   
*Gupta, R.  1993.  A short history of neuropathic arthropathy.  [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8222448&dopt=Abstract Clinical Orthopaedics], 296, pp. 43-49.   
*Sommer, Todd C., and Lee, Thomas H.  Charcot Foot:  The Diagnostic Dilemma.  [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11730314&dopt=Abstract American Family Physician.  Vol. 64, No. 9, Nov. 1, 2001].
*Sommer, Todd C., and Lee, Thomas H.  Charcot Foot:  The Diagnostic Dilemma.  [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11730314&dopt=Abstract American Family Physician.  Vol. 64, No. 9, Nov. 1, 2001].


[[Category:Rheumatology]]
[[Category:Rheumatology]]

Latest revision as of 20:39, 16 November 2012

Neuropathic joint disease
DiseasesDB 2344

WikiDoc Resources for Neuropathic joint disease

Articles

Most recent articles on Neuropathic joint disease

Most cited articles on Neuropathic joint disease

Review articles on Neuropathic joint disease

Articles on Neuropathic joint disease in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Neuropathic joint disease

Images of Neuropathic joint disease

Photos of Neuropathic joint disease

Podcasts & MP3s on Neuropathic joint disease

Videos on Neuropathic joint disease

Evidence Based Medicine

Cochrane Collaboration on Neuropathic joint disease

Bandolier on Neuropathic joint disease

TRIP on Neuropathic joint disease

Clinical Trials

Ongoing Trials on Neuropathic joint disease at Clinical Trials.gov

Trial results on Neuropathic joint disease

Clinical Trials on Neuropathic joint disease at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Neuropathic joint disease

NICE Guidance on Neuropathic joint disease

NHS PRODIGY Guidance

FDA on Neuropathic joint disease

CDC on Neuropathic joint disease

Books

Books on Neuropathic joint disease

News

Neuropathic joint disease in the news

Be alerted to news on Neuropathic joint disease

News trends on Neuropathic joint disease

Commentary

Blogs on Neuropathic joint disease

Definitions

Definitions of Neuropathic joint disease

Patient Resources / Community

Patient resources on Neuropathic joint disease

Discussion groups on Neuropathic joint disease

Patient Handouts on Neuropathic joint disease

Directions to Hospitals Treating Neuropathic joint disease

Risk calculators and risk factors for Neuropathic joint disease

Healthcare Provider Resources

Symptoms of Neuropathic joint disease

Causes & Risk Factors for Neuropathic joint disease

Diagnostic studies for Neuropathic joint disease

Treatment of Neuropathic joint disease

Continuing Medical Education (CME)

CME Programs on Neuropathic joint disease

International

Neuropathic joint disease en Espanol

Neuropathic joint disease en Francais

Business

Neuropathic joint disease in the Marketplace

Patents on Neuropathic joint disease

Experimental / Informatics

List of terms related to Neuropathic joint disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Charcot joints; neuropathic arthropathy; neuropathic osteoarthropathy

Overview

Neuropathic osteoarthropathy refers to progressive degeneration of a weight-bearing joint, a process marked by bony destruction, bone resorption, and eventual deformity. Onset is usually insidious. It is also known as Charcot joint.

If this pathological process continues unchecked, it could result in joint deformity, ulceration and/or superinfection, loss of function, and in the worst case scenario: amputation. Early identification of joint changes is the best way to limit morbidity.

Pathophysiology

  • Two primary theories have been advanced:
    • Neurotrauma: Loss of peripheral sensation and proprioception leads to repetitive microtrauma to the joint in question; this damage goes unnoticed by the neuropathic patient, and the resultant inflammatory resorption of traumatized bone renders that region weak and susceptible to further trauma. Indeed, it is a vicious cycle. In addition, poor fine motor control generates unnatural pressure on certain joints, leading to additional microtrauma.
    • Neurovascular: Neuropathic patients have dysregulated autonomic nervous system reflexes, and de-sensitized joints receive significantly greater blood flow. The resulting hyperemia leads to increased osteoclastic resorption of bone, and this, in concert with mechanical stress, leads to bony destruction.

In reality, both of these theories probably play a role in the development of a Charcot joint.

Causes

Basically, any condition resulting in decreased peripheral sensation, proprioception, and fine motor control:

Differentiating Neuropathic joint disease from other Diseases

Note that it is often difficult to differentiate osteomyelitis from a Charcot joint, as they may have similar tagged WBC scan and MRI features (joint destruction, dislocation, edema). Definitive diagnosis may require bone or synovial biopsy.

Diagnosis

History and Symptoms

As diabetes is the #1 cause in America today for neuropathic joint disease, the foot is the most affected region. In those with foot deformity, approximately 60% are in the TMT joint (medial > lateral), 30% MCP joint, and 10% have ankle disease. Over half of diabetic patients with neuropathic joints can recall some kind of precipitating trauma, usually minor.

Patients with neurosyphilis tend to have knee involvement, and patients with syringomyelia of the spinal cord may demonstrate shoulder deformity.

Hip joint destruction is also seen in neuropathic patients.

Physical Examination

Erythema, edema, increased temperature in the affected joint. In neuropathic foot joints, plantar ulcers may be present.

X Ray

First, it is important to recognize that two types of abnormality may be detected. One is termed "atrophic," in which there is osteolysis of the distal metatarsals in the forefoot. The more common form of destruction is "hypertrophic" joint disease, characterized by acute peri-articular fracture and joint dislocation.

The natural history of the joint destruction process has a classification scheme of its own, offered by Eichenholtz decades ago:

Stage 0: Clinically, there is joint edema, but radiographs are negative. Note that a bone scan may be positive before a radiograph is, making it a sensitive but not very specific modality.

Stage 1: Osseous fragmentation with joint dislocation seen on radiograph ("acute Charcot").

Stage 2: Decreased local edema, with coalescence of fragments and absorption of fine bone debris

Stage 3: No local edema, with consolidation and remodeling (albeit deformed) of fracture fragments. The foot is now stable.

Destroyed TMT joints in the medial left foot, with fracture and dislocation of fragments; these are classic findings. Also note loss of the foot arch and acquired pes planus deformity.

Treatment

Once the process is recognized, immobilization with a total contact cast will help ward off further joint destruction. Pneumatic walking braces are also used. Surgical correction of a joint is rarely successful in the long-term in these patients.

It can take 6-9 months for the edema and erythema of the affected joint to recede.

References

Template:WH Template:WikiDoc Sources